A detailed history of Ggm Financials LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ggm Financials LLC holds 6,895 shares of ABBV stock, worth $1.38 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
6,895
Previous 6,845 0.73%
Holding current value
$1.38 Million
Previous $1.17 Billion 15.98%
% of portfolio
1.17%
Previous 1.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $8,192 - $9,966
50 Added 0.73%
6,895 $1.36 Billion
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $1.06 Million - $1.24 Million
6,845 New
6,845 $1.17 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ggm Financials LLC Portfolio

Follow Ggm Financials LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ggm Financials LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ggm Financials LLC with notifications on news.